Jefferies Assumes Coverage on Amedisys (AMED) at Hold; Medicare Cuts Equal Fully Valued
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Jefferies assumes coverage on Amedisys (NASDAQ: AMED) with a Hold. PT $14.00 (from $13.00).
Analyst, Brian Tanquilut, said, "While we are encouraged by AMED's improving admissions trends, the (1) new headwind from its HUM contract renegotiation, (2) potential Medicare rate cuts early next year, (3) the scheduled release of the rebasing rule in mid-2013, and (4) the stock's recent run-up make us conclude that AMED is fully valued at current levels."
Lowers FY12 EPS estimates from $1.01 to $1.00, but raises FY13 from $0.81 to $0.91.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $15.31 yesterday.
Analyst, Brian Tanquilut, said, "While we are encouraged by AMED's improving admissions trends, the (1) new headwind from its HUM contract renegotiation, (2) potential Medicare rate cuts early next year, (3) the scheduled release of the rebasing rule in mid-2013, and (4) the stock's recent run-up make us conclude that AMED is fully valued at current levels."
Lowers FY12 EPS estimates from $1.01 to $1.00, but raises FY13 from $0.81 to $0.91.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $15.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
- Jefferies Assumes Honeywell International (HON) at Hold
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share